Update: SpaceX postponed Friday's launch. The news liftoff is expected Saturday, November 18, 2023 with a 20-minute window opening at 8:00 a.m. ET.

By Marcia Dunn

SpaceX is aiming for another test flight of its mega rocket on Friday after getting final approval from federal regulators.

The first launch of Starship ended in an explosion minutes after lifting off from South Texas in April.

The Federal Aviation Administration issued its license Wednesday, noting that SpaceX has met safety, environmental and other requirements to launch again. Elon Musk's rocket company said it was targeting Friday morning.

After the self-destruct system blew up the rocket over the Gulf of Mexico, SpaceX made dozens of improvements to the nearly 400-foot (121-meter) rocket and to the launch pad, which ended up with a large crater beneath it.

SpaceX has a $3 billion NASA contract to land astronauts on the lunar surface as early as 2025, using the spacecraft.

A month ago, the FAA completed its safety review of the upcoming Starship launch. It needed more time to wrap up its environmental review. No one was injured in the first attempt, but the pad was heavily damaged as the rocket's 33 main engines ignited at liftoff.

The U.S. Fish and Wildlife Service later reported that concrete chunks, steel sheets and other objects were hurled thousands of feet (hundreds of meters) from the pad. It also said a plume of pulverized concrete sent material several miles (up to 10 kilometers) away.

Wildlife and environmental groups sued the FAA over what they considered to be the FAA’s failure to fully consider the environmental impacts of the Starship program near Boca Chica Beach.

Plans call for the test flight to last 1 /1/2 hours and fall short of a full orbit of Earth. The spacecraft would go eastward, passing over the Atlantic, Indian and Pacific oceans before ditching near Hawaii. Nothing of value will be on board.

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

Updated November 17, 2023 at 8:53 a.m. ET with time for new launch attempt.

Share:
More In Science
As U.S. Opioid Crisis Worsens, Price of Life-Saving Drug Naloxone Skyrockets
Jill Wagner and Baker Machado break down the state of the Opioid Crisis in the U.S. The CDC reported a 30% increase in overdose deaths from 2020 to 2021, but in recent months pharmaceutical companies have drastically raised the price of Naloxone or 'Narcan,' affecting the response of community harm prevention groups.
Regeneron Joins Battle Against COVID-19, Releases Stats on New COVID Treatment
The world hit a grim milestone on Monday, with COVID-19 cases surpassing a quarter of a billion worldwide. As cases increase, the fight to beat the virus continues as well, with a number of medical breakthroughs coming out over the last few months in the form of pills from Pfizer and Merck. Regeneron is now the latest company to join the fight, recently releasing new data on a covid antibody cocktail. Professor Peter Pitts, former FDA Associate Commissioner and the founder of the Center for Medicine in the Public Interest breaks down the differences between the 3 treatments and why vaccines are still among the fire line of defense.
Legal Questions Swirl as States Push Back Against Biden COVID Vaccine Mandate
The Biden Administration's mandate for COVID vaccinations by large employers has been put on hold by federal courts as GOP-led states and some businesses push back on the order's legality. Jonathan Adler, a law professor at Case Western Reserve University, joined Cheddar to discuss the legal challenges to implementing such mandates through OSHA (Occupational Safety and Health Administration). "Certainly expanding vaccinations is a good thing, and as vaccination rates go up that's better for all of us," Adler said. "But there are some legal questions about whether or not it's appropriate to use a law about occupational safety and health as the means to do that."
What COVID-19 Vaccines for Kids Might Mean for Fight Against Pandemic
Dr. Robert Frenck, an infectious disease specialist at Cincinnati Children's Hospital, joined Cheddar to talk about the significance of children ages 5-11 being authorized to receive COVID-19 vaccinations. He also discussed schools being cleared to administer vaccines and noted the importance of meeting people where they are rather than forcing them to find the shots. Frenck also said he expects that children under 5 years old will begin getting vaccinations sometime in spring.
Everything You Need to Know About Child Covid-19 Vaccines
A CDC advisory committee as unanimously voted to recommend the Pfizer Covid-19 vaccine in children ages 5 to 11. Dr. Amesh Adalja, Infectious Disease Specialist and Senior Scholar at Johns Hopkins Center for Health Security, joined Cheddar News to discuss.
Load More